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ABSTRACT
Although microRNAs (miRNAs) are key regulators
of gene expression, little is known of their overall
persistence in the cell following processing.
Characterization of such persistence is key to the
full appreciation of their regulatory roles.
Accordingly, we measured miRNA decay rates in
mouse embryonic fibroblasts following loss of
Dicer1 enzymatic activity. The results confirm the
inherent stability of miRNAs, the intracellular levels
of which were mostly affected by cell division. Using
the decay rates of a panel of six miRNAs represen-
tative of the global trend of miRNA decay, we estab-
lish a mathematical model of miRNA turnover and
determine an average miRNA half-life of 119h (i.e.
 5 days). In addition, we demonstrate that select
miRNAs turnover more rapidly than others. This
study constitutes, to our knowledge, the first
in-depth characterization of miRNA decay in mam-
malian cells. Our findings indicate that miRNAs are
up to 10  more stable than messenger RNA and
support the existence of novel mechanism(s)
controlling selective miRNA cellular concentration
and function.
INTRODUCTION
It is now well-established that microRNAs (miRNAs) are
master regulators of most cellular processes. Many viruses
utilize viral-encoded miRNAs during their infectious cycle
(1), mice lacking miRNAs are not viable (2,3) and miRNA
levels are altered in most cancers (4). miRNAs are short
single-stranded RNAs of  22nt processed from longer
RNA primary transcripts (pri-miRNAs) with high second-
ary structure. Canonical processing of pri-miRNA into
mature miRNA requires sequential cleavage of the pri-
miRNA into a  70-nt miRNA precursor by the endo-
nuclease Drosha (5), and subsequent cleavage into a
 20-bp miRNA duplex by the endonuclease Dicer1 (6).
One strand of this duplex is loaded onto the RNA-induced
silencing complex (RISC) forming the miRISC regulat-
ing cognate messenger RNA (mRNA) stability in GW
bodies (7).
The canonical biogenesis of miRNAs is regulated by
several mechanisms that directly impact on the overall
production of mature miRNAs (8). For instance,
LIN-28 affects the processing of let-7 precursors by
Drosha and Dicer1, allowing it to speciﬁcally switch-off
the production of mature forms of let-7 in undifferentiated
embryonic stem cells (8,9). Such regulation of miRNA
processing ﬁne-tunes their intracellular levels, and modu-
lates their biological activity. Indeed, miRNA intracellular
concentration directly relates to their ability to affect
mRNA translation with a suggested threshold of about
100 molecules per cell required for function (10).
Because the intracellular miRNA steady-state levels
result from not only the synthesis of new miRNAs but
also the degradation of previously synthesized miRNAs,
characterization of miRNA persistence following process-
ing is crucial to the understanding of their biological
function.
However, what happens to mature miRNAs is currently
poorly understood, and their overall persistence following
Dicer1 processing is inferred to be ‘highly stable’ from
studies of select miRNAs (8,11). For instance, miR-208
was found to persist in the absence of its precursor for
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unchanged following rapid decrease of pri-miR-122 in
liver tissue (13). Conversely, a rapid decrease of
miRNAs has been observed in neuronal cells, following
blocking of pri-miRNA transcription (14). Furthermore,
selective miRNA stability has been proposed to be
impacted on by various factors, including 30 base modiﬁ-
cations (15), the degree of complementarity to the target
(16) or target abundance (17). With the exception of
miR-451 (18), miRNAs are dependent on Dicer1 matur-
ation to be able to exert their regulatory function (19,20).
Consequently, different approaches have been developed
to disrupt Dicer1 function and characterize the regulatory
roles of miRNAs. To our knowledge, the use of an indu-
cible deletion of Dicer1 to address miRNAs decay has not
been previously adopted.
Here, we investigate the stability of miRNAs following
a global shutdown of miRNA synthesis. Relying on the
inducible genetic ablation of Dicer1 in immortalized em-
bryonic ﬁbroblast cells, we modelled miRNA decay in a
theoretical non-dividing cell and established that the
average miRNA half-life is about 10  that of mRNA,
i.e. about 5 days. In addition, we observed signiﬁcant vari-
ations in select miRNA half-lives, thereby supporting
the existence of novel mechanism(s) regulating miRNA
function through ﬁne-tuning of steady-state miRNA levels.
METHODS
Ethics statement
The use of animals and experimental procedures were
approved by Monash Medical Centre Ethics Committee
under references MMCA/2008/26/BC and MMCA
2007/07.
Cell culture
Dicer1
ﬂox/ﬂox mice (a kind gift from M. McManus,
University of California, San Francisco, CA, USA) (21)
were bred to R26CreER mice expressing the Cre/Esr1
fusion protein from the ROSA26 locus (22). Mouse em-
bryonic ﬁbroblasts (MEFs) from Day 14 embryos were
immortalized following transfection of pSG5-SV40-LT-
Ag (a kind gift from D. Huang, Walter and Eliza Hall
Institute of Medical Research, Melbourne, Australia)
and six successive 1/10 passages. For stable enhanced
green ﬂuorescent protein (EGFP) expression, the MEFs
were transduced with an EGPF-expressing lentiviral con-
struct (pLV-CMV-GFP). Bone marrow was isolated from
the femurs of Dicer1
ﬂox/ﬂox xCre/Esr1 mice, and primary
bone marrow derived macrophages (BMDMs) were
differentiated in 20% L929-cell-conditioned medium for
7 days at 37 C in a 5% CO2 atmosphere. BMDMs,
MEFs and HEK293T cells stably expressing GFP (23)
were cultured in complete Dulbecco’s modiﬁed Eagle’s
medium (DMEM) (cat. no. 11965-092; Invitrogen
Corporation, Carlsbad, CA, USA) supplemented with
10% sterile foetal bovine serum (#FBS-500, ICPBio Ltd,
Auckland, New Zealand) and 1  antibiotic/anti-mycotic
(Invitrogen) (referred to as complete DMEM). Splenic B
cells were puriﬁed using a B Cell Isolation Kit (depletion
of non-B cells) from Miltenyi Biotech. Purity was >95%.
Activation of splenic B lymphocytes was performed in
Roswell Park Memorial Institute (RPMI) 1640+L-glu-
tamine medium (#11875085, Invitrogen) supplemented
with 10% FBS, 55mM b–mercaptoethanol, 2mM L-glu-
tamine, 10mM HEPES and 100U/ml of penicillin–
streptomycin, and cells were stimulated with LPS (25mg/
ml, InvivoGen, San Diego, CA, USA) and murine inter-
leukin 4 (10ng/ml, eBioscience, San Diego, CA, USA) for
the indicated amount of time.
OHT treatment of the cells
Hydroxy-tamoxifen (OHT) (H7904-5mg, Sigma Aldrich,
St Louis, MO, USA) was resuspended in 0.5ml of 100%
ethanol (resulting in stock solution at  25mM) kept at
 80 C. Prior to cell treatment, the stock solution was ﬁrst
diluted to 2.5mM in 100% ethanol before being diluted
further to the ﬁnal concentration in complete DMEM.
For OHT treatment of BMDMs, the cells were differ-
entiated in 20% L929-cell-conditioned medium, and
were washed on Day 3 with fresh medium supplemented
with 20% L929-cell-conditioned medium and 500nM
OHT. The cells were collected on Day 5 and plated in
24-well plates in 20% L929-cell-conditioned medium,
and collected at Days 6–9 for RNA extraction.
Reverse transcription quantitative real-time PCR
Total RNA containing small RNAs was puriﬁed from
cultured cells using an adapted RNeasy protocol
(Qiagen, Valencia, CA, USA) or the mirVana miRNA
isolation kit (Ambion, Austin, TX, USA). For mRNA
quantiﬁcation, cDNA was synthesized from isolated
RNA using the High-capacity cDNA archive kit
(Applied Biosystems, Foster City, CA, USA) according
to the manufacturer’s instructions. Reverse transcription
quantitative real-time polymerase chain reaction
(RT-qPCR) was carried out with the SYBR GreenER
TM
qPCR SuperMix for iCycler instrument (#11761-500;
Invitrogen Corporation). Murine glyceraldehyde 3-
phosphate dehydrogenase (mGAPDH) (NM_008084)
was used as reference gene and ampliﬁed with the follow-
ing primer pair: mGAPDH-FWD: TTCACCACCATGGA
GAAGGC; mGAPDH-REV: GGCATGGACTGTGGTCA
TGA. Detection of the primary miRNAs was carried out
with the following primer pairs: Mir155 (NR_029565.1)—
pri-miR-155-FWD: AAACCAGGAAGGGGAAGTGT
(24); pri-miR-155-REV: ATCCAGCAGGGTGACTCTTG
(24); Mir146a (NR_029558.1)—pri-miR-146a-FWD: GTG
TGTATCCCCAGCTCTGA; pri-miR-146a-REV: CTTCA
CCCCACTCTCTCCAC; Mir21 (NR_029738.1)—
pri-miR-21-FWD: TGTACCACCTTGTCGGATAGC;
pri-miR-21-REV: AAGGGCTCCAAGTCTCACAA. Wild-
type Dicer1 mRNA (NM_148948.2) was detected with
mDicer1-RT-FWD: TCTGCAGGCTTTTACACACG and
mDicer1-Exon-REV: CCAATGATGCAAAGATGGTG.
Each amplicon was sequence veriﬁed and used to generate
a standard curve for the quantiﬁcation of gene expression.
For mature miRNA detection, miRNA TaqMan assays
(Applied Biosystems) for the indicated miRNAs were
used according to the manufacturer’s instructions, where
Nucleic Acids Research, 2011,Vol.39, No. 13 569310–30ng of total RNA was reverse transcribed with pools
of up to eight miRNA-speciﬁc reverse transcription
primers (with the TaqMan MicroRNA Reverse
Transcription Kit). With the exception of mmu-miR-155
and snoRNA202, all the individual Taqman assays used
were compatible between human and mouse. miRNA
levels were determined by RT-qPCR with the TaqMan
Universal PCR Master Mix on a 7900 RT-PCR system
(Applied Biosystems), and fold changes in expression were
calculated by the 2
   Cq (Cq=quantiﬁcation cycle)
method using snoRNA202 (for all mouse experiments),
or miR-16 (for HEK293T cells) as reference genes.
Low density miRNA arrays
TaqMan Array Rodent MicroRNA (A Cards v2.0,
Applied Biosystems) were used for the global detection
of miRNAs from one biological sample set. Brieﬂy,
900ng of total RNA containing small RNAs was reverse
transcribed using the Megaplex
TM RT Primers, Rodent
Pool A (Applied Biosystems) with the TaqMan
MicroRNA Reverse Transcription Kit and each plate
was consecutively ran using the TaqMan Universal
Master Mix II on the 7900 RT-PCR system, according
to the manufacturer’s instructions. Simultaneous analysis
of the three different plates (one plate at Days 3–5) was
carried out using the RQ Manager software. To determine
signiﬁcant miRNA expression, we performed the follow-
ing ﬁltering. (i) We only considered miRNAs that had Cq
values lower than 37 for all three time-points. (ii) We used
the average of four RNAU6 probes present on each array
as reference gene (giving  Cq values), and calculated
  Cq values using Day 3 as control condition. Fold
decrease of miRNA levels relative to Day 3 was inferred
using 2
(   Cq) values. (iii) We limited our analysis to
miRNAs levels that consistently decreased with time (i.e.
Day 3>Day 4>Day 5)—hereby identifying 104
miRNAs. Importantly, out of the 158 miRNAs detected
by PCR-array with Cqs inferior to 37 at each time-point,
17 were such that the concentrations of miRNAs at Day
3>Day 4 and Day 3>Day 5 but not Day 4>Day 5, 21
had increased miRNA expression at either Day 4 or Day 5
compared with Day 3 (most likely from technical PCR
outlier) and 17 did not decrease with time (i.e. Day
3 Day 4 Day 5) (Supplementary Table S1). Recent
evidence suggests that ﬁve of these non-decreasing
RNAs (miR-509-3p, miR-658, miR-207, miR-680 and
miR-687—see Supplementary Table S1 in bold) would in
fact not be miRNAs (25), hence validating our method of
discrimination and the robustness of the RT-qPCR array
platform. Our data on 104 miRNAs, therefore, rely on 3/4
of the miRNA possibly expressed by the MEFs, and a less
conservative approach including the 17 miRNAs with
decreased expression at Days 4 and 5 compared with
Day 3 gave very similar averaged decrease (data not
shown). Similar results were obtained using normalization
to other controls such as snoRNA202 or snoRNA135.
To account for possibly rapidly decaying miRNAs that
would not be detected after Day 3, we also analysed the
global trend of miRNA decay between Days 3 and 4
(Supplementary Table S2), and Days 4 and 5
(Supplementary Table S3), including miRNAs that were
not detected at one of the time-points (Cq=40). (i) We
only considered miRNAs that had Cq values lower than
40 at Day 3, and (ii) that had a lower Cq value at Day 3
than Day 4. One hundred and eighty-three miRNAs
matched these criteria, with an averaged 64% decrease
of miRNA expression between Days 3 and 4 (when
normalized to RNAU6 as detailed above). (iii) We next
repeated this analysis and assessed the expression of
miRNAs between Days 4 and 5, ﬁltering miRNAs that
had Cq values lower than 40 at Day 4, and a lower Cq
value at Day 4 than Day 5. One hundred and ﬁfty-four
miRNAs matched these criteria, with an averaged 68%
decrease of miRNA expression between Days 4 and 5.
These data, although approximate given that the
non-detected miRNAs were attributed an arbitrary Cq
value of 40, support our claim that the global trend of
miRNA decay is constant between Days 3 and 4, and 4
and 5, even when including miRNAs that are possibly
rapidly degraded.
Synthetic RNAs
All small interfering RNA (siRNA) and si-miRNA
duplexes were synthesized as single-stranded RNAs by
Integrated DNA Technologies (IDT) with HPLC puriﬁ-
cation, and resuspended in duplex buffer (100mM potas-
sium acetate, 30mM HEPES, pH 7.5, DNase–RNase free
H2O) to a concentration of 80mM. Annealing was per-
formed by incubating the complementary single-stranded
RNAs at 92 C for 2min and leaving them for 30min at
room temperature (giving a ﬁnal concentration of 40mM).
miR-155-S: 50 CCCUAUCACAAUUAGCAUUAAUU;
miR-155-AS: 50 UUAAUGCUAAUUGUGAUAGGGG
U. miR-21-S: 50 AACAUCAGUCUGAUAAGCUAUU;
miR-21-AS: 50 UAGCUUAUCAGACUGAUGUUGA.
Reverse transfection of small RNAs
For Figure 1D, 4.5ml of Lipofectamine 2000 was diluted
in 300ml of Opti-MEM and 2.25ml of mi-siRNA mol-
ecules (diluted to 4mM in duplex buffer) was added such
that the ﬁnal concentration of each siRNA was 5nM per
well (the volumes indicated are for biological triplicate).
After 20min of incubation, 100ml of the mix was added
directly into each well of a 24-well plate. HEK293T-GFP
cells (100 000) resuspended in 500ml of antibiotic-free
DMEM (supplemented with 10% FBS) were added to
each well giving a ﬁnal volume of 600ml/well. The cells
were incubated at 37 C for 7h before being washed with
fresh medium. For Figure 2B, 4.8ml of Lipofectamine
2000 was diluted in 300ml of Opti-MEM and 3mlo f
siRNA molecules (diluted to 4mM in duplex buffer) was
added such that the ﬁnal concentration of siRNA in each
well was 10nM (the volumes indicated are for biological
triplicate in two cell types). After 20min of incubation,
50ml of the mix was added directly into each well of a
96-well plate (in triplicate for each cell type). MEFs (20
000; previously treated with OHT or not) in 150mlo f
antibiotic-free DMEM (supplemented with 10% FBS)
were added to each well giving a ﬁnal volume of 200ml/
well.
5694 Nucleic Acids Research, 2011,Vol.39, No. 13Fluorescent-based measure of EGFP knockdown
EGFP down-regulation in MEFs stably expressing EGFP
cells was measured using a Fluostar OPTIMA
plate-reader as previously reported (23). After 24h
siRNA treatment, the supernatants were discarded and
50ml of PBS was added to the cells. A standard curve
was generated by serially diluting a recombinant
EGFP-fusion protein to cover a range from 150ng/ml to
4.68ng/ml in 50ml PBS. EGFP concentration in each well
was then inferred from the ﬂuorescence at ex485/em520
correlated to the standard curve, after background
autoﬂuorescence (from PBS only) correction.
High-content screening assay
Cell proliferation was assayed using high-content screen-
ing assay (HCSA) with a Cellomics ArrayScan HCS
Reader (Thermo Fisher Scientiﬁc). EGFP cells were
counted per captured ﬁeld according to ﬂuorescent inten-
sity and morphology (with the HCS Reader V-6.6.1.2
software, Thermo Fisher Scientiﬁc), up to 3000+ cells
per well. The average number of cells per ﬁeld was used
as a quantiﬁcation of cell number at each time-point.
Mathematical modelling
To build a mathematical model of miRNA degradation
independent of recombination efﬁciency and cell prolifer-
ation, we decomposed our analysis in three independent
steps. We ﬁrst established a model of the intracellular
miRNA concentration per cell (yi=y1,...,yn) following
entire blockage of de novo miRNA synthesis, function of
time (ti=t 1,...,t n) and assuming that it was solely
impacted by the amount of cells that had divided (and
that each cell division halved the initial concentration of
miRNA). We obtained experimental values from the
averaged cell proliferations at different time-points
(Supplementary Figure S3B, see ‘measured’ curve).
Relying on this data set, we modelled miRNA decay due
to cell proliferation under the assumption that this
function is an exponential decay: FcellP (t)=a exp (–cti),
where a is the initial quantity at time t1, and c is the
constant of decay. To identify the co-efﬁcients a and c,
we used a non-linear least-square ﬁtting algorithm. The
method is based on the minimization of the distance (or
error) D between the function FcellP (ti) and the data at all
points yi. The distance D is deﬁned as:
DðrÞ¼
Xn
i¼1 jFcellPðti,rÞ yij2
where r(a, c) is the vector with adjustable parameters of
function FcellP. The minimization of the function D (r)
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Figure 1. Sustained persistence of innate immune miRNAs in the
absence of their precursors. (A–C) BMDMs were treated with 10ng/
ml of LPS and incubated for the indicated time before being lysed in
RNA extraction buffer. Expression levels of pri- and mature miRNAs
were determined by RT-qPCR, reported to that of the internal control
(GAPDH and snoRNA-202, for the pri-miRNA and the mature
miRNA, respectively) and are shown relative to the values at the
initial time-point. The values are averaged from three biological repli-
cates, and are representative of two independent experiments.
(D) HEK293T-GFP cells were reverse-transfected with 5nM of both
si-miR-21 and si-miR-155 synthetic miRNAs, washed with fresh
medium after 7h and collected in RNA extraction buffer at the
indicated times. miRNA levels were determined by RT-qPCR
reported to the expression of the house-keeping control RNA
miR-16. The values are presented relative to that at the initial
time-point, averaged from three biological replicates and are represen-
tative of three independent experiments. (A–D) Standard error of the
mean (SEM) is shown.
Nucleic Acids Research, 2011,Vol.39, No. 13 5695with respect to the parameter vector r required the zero
gradient condition:
rDðrÞ¼JTðFcellPðrÞ yÞ¼0,
where J is Jacobian. The values of the vector r are
obtained using the Newton–Raphson iteration method.
The process starts with an initial parameter vector r0
(a0, c0) and is corrected to be ri=r0+ ri in the next it-
eration. The increment parameter vector  r therefore
satisﬁes the system of linear equations:
 r ¼  H 1JTðFcellPðrÞ yÞ
and H can be approximated by H=J
TJ for a system with
moderate non-linearity.
The second step of modelling deﬁnes a function of
miRNA intracellular concentration averaged from two
distinct cell populations; one population lacking de novo
miRNA synthesis (ensuing Dicer1 genetic ablation)
f1 (t)=b exp ( k1t), and the other that escaped Dicer1
recombination and producing normal levels of miRNAs
f2 (t)=b (1 k2t), where b is the initial quantity at the
start time t1. The sum of these two functions models the
experimental measurements of the average miRNA con-
centration per cell yi at a time ti. As a result we obtain the
function F (t)=b (m exp ( k1t)+(1 m)( 1–k2t)), where
m is the relative proportion of the two cell populations
(0 m 1), and was experimentally determined by the
quantiﬁcation of wild-type Dicer1 mRNA by RT-PCR
(Figure 3A). We estimated parameters k1, k2 and b with
m=0.995 of recombined cells (Figure 3A and C; 500nM),
applying the non-linear least-square ﬁtting algorithm ex-
plained above (the resulting ﬁtted model curve is shown in
Figure 3D, FM-99.5%). Next, we validated the relevance
of our model by changing the relative proportions of the
mixed cell population to m=0.5 (i.e. 50% of recombined
cells—Figure 3D, see curve M-50%) and also to m=1
(i.e. where 100% of the cells would lack de novo miRNA
synthesis and consequently where F (t)=f1 (t), Figure 3D,
see curve M-100%).
For the last step of our analysis, we assessed the intra-
cellular miRNA decrease that is independent of that due
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Figure 2. Determination of global miRNA decay. (A) Actively dividing Dicer1
ﬂox/ﬂoxxCre/Esr1 MEFs were treated overnight with the indicated
concentration of OHT, washed with fresh medium and further incubated for 48h before being harvested for RNA extraction. Wild-type Dicer1
mRNA was quantiﬁed by RT-qPCR and reported to the expression of GAPDH. The data are presented relative to that obtained without OHT
treatment (condition ‘0’), are averaged from biological duplicate and are representative of three independent experiments. (B) Actively dividing
Dicer1
ﬂox/ﬂoxxCre/Esr1 GFP MEFs were treated (OHT) or not (NT) overnight with 500nM OHT, and expanded for a further 48h before being
collected and reverse transfected (on Day 3 following initial OHT addition) with 10nM of the indicated siRNAs. The cells were further incubated for
24h and EGFP expression was quantiﬁed by ﬂuorescent spectrophotometer [see ‘Methods’ section and (23)]. The data are averaged from two
independent experiments in biological triplicate and normalized to the averaged values obtained for the non-targeting siEGFP-N-MIS sequence for
each cell type. siEGFP-N-MIS contains two mismatches in the targeting strand of the siRNA compared to siEGFP-N and both siRNAs are Dicer1
substrates (Supplementary Figure S1C); siGFP19+2 is a Dicer1 product (23). (C and D) Actively dividing Dicer1
ﬂox/ﬂoxxCre/Esr1 MEFs treated with
500nM OHT were expanded and collected at Days 3–5 following initial OHT treatment. For each miRNA measured, the levels were reported to that
obtained at Day 3 (T=72h following OHT treatment). (C) The average level of 104 miRNAs signiﬁcantly detected by low-density PCR microarray
(‘Methods’ section and Supplementary Table S1) is shown with ﬁtted exponential regression. (D) Individual miRNA PCRs were carried out on the
samples analysed with low-density PCR microarray and biological replicates. Highlighted in grey is the variation of miRNA decay observed between
the six miRNAs analysed, and ﬁtted exponential regression is shown for miR-125b and miR-155. The data are averaged from biological triplicate
and are representative of three independent experiments. SEM (B and D) and standard deviation (SD) (C) are shown.
5696 Nucleic Acids Research, 2011,Vol.39, No. 13to cell division—referred to as the ‘absolute’ miRNA
decay. We established a function of the difference between
the function of miRNA decrease solely due to cell prolif-
eration FcellP (t) and the function of miRNA decrease
inferred from our experiments in a cell population
entirely lacking de novo miRNA synthesis F (t)=f1 (t)
where m=1. We assumed from our observations in
BMDMs that such ‘absolute’ miRNA degradation func-
tion ﬁts an exponential decay (Figure 4C), and speciﬁed
the following:
FabsoluteðtÞ¼  expð dtÞ:
To determine the co-efﬁcients g and d, we relied on the
fact that experimentally inferred F(t) is included in the
Fabsolute (t) and the miRNA decrease due to cell prolifer-
ation FcellP (t). Hence
FðtÞ¼FcellPðtÞ FabsoluteðtÞ,orFðtÞ
¼ zexpð ctiÞ   expð dtÞ:
We determined the parameters z, g and d relying on the
same non-linear ﬁtting algorithm. The ‘absolute’ miRNA
half-life, independent of cell proliferation in a cell popu-
lation entirely devoid of de novo miRNA synthesis, was
then calculated based on the decay constant d as follows:
t1=2¼
lnð2Þ
d
:
RESULTS
Persistence of miR-155, miR-146a and miR-21
With the aim of better understanding their role in the
regulation of macrophage function, we originally investi-
gated the persistence of three miRNAs (miR-155, miR-
146a and miR-21) that are rapidly induced in immune
cells following stimulation with pathogen-derived
products (26,27). Stimulation of primary BMDMs with
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Figure 3. Model of miRNA decay based on experimental measurements. (A–C) Dicer1
ﬂox/ﬂoxxCre/Esr1 GFP MEFs were plated at low density
(10000 cells per well of a 6-well plate) and treated for  16h with the indicated concentrations of OHT (NT is non-treated). Approximately 64h
following the initial OHT treatment (and every 8h from then on), some wells were harvested for RNA extraction and cell numbers were quantiﬁed
using HCSA (‘Methods’ section). (A) GAPDH-normalized wild-type Dicer1 mRNA levels quantiﬁed by RT-qPCR were reported to values obtained
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10nM OHT condition. (E) Following the determination of M-100% and miRNA decay relating to cell proliferation (Cell proliferation—see
Modelling in ‘Methods’ section), we determined the ‘absolute’ miRNA decay in a theoretical non-dividing cell (highlighted in purple) for the
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miR-125b and miR-155 are also shown; highlighted in orange is the variation of miRNA decay observed between the six miRNAs analysed. The
experimental data used for the modelling are representative of two independent experiments.
Nucleic Acids Research, 2011,Vol.39, No. 13 5697lipopolysaccharide (LPS) resulted in the rapid and tran-
sient induction of the respective primary transcripts of
each miRNA (with a peak of expression between 4h and
8h returning to lower levels by 24h) (Figures 1A–C).
Conversely, the overall levels of the three mature
miRNAs accumulated over the 48–72h period, with the
exception of miR-155 which decreased by 25% after 48h
(that is  40h after the initial decrease of pri-miR-155).
This discrepancy between precursor and mature miRNA
levels indicated that degradation of mature miRNAs was
much slower than the upstream processing of pri-
miRNAs. Similar observations were made for miR-155
and miR-21 in splenic B cells, supporting the concept that
the persistence of these miRNAs was not cell speciﬁc
(Supplementary Figure S1A and B). To rule out a
putative speciﬁc stabilization of the induced forms of
these miRNAs, we next addressed the stability of
transfected synthetic mature miRNA mimics (si-miRNAs).
Such mimics are based on a duplex with 30-2nt overhang
consisting of the mature miRNA sequence and its perfectly
matching complementary strand and have been shown to
recapitulate localization and degradation similar to that
of mature miRNAs (28). Following transfection of the
si-miRNAs into HEK293 cells, we observed that the
decrease of mature miR-155 and miR-21 levels (which
exceeded their respective basal endogenous levels by sev-
eral 100-fold—Figure 1D compare 0 and 7h time-points)
was also relatively slow ( 50% in 17h) and in fact could
mostly be attributed to cell division (Figure 1D, and data
not shown). Collectively, these results suggested that the
mature forms of miR-155, miR-21 and miR-146a were
long-lived following processing, independently of their
expression.
Global persistence of miRNA following Dicer1 processing
The impressive stability of miR-155, miR-21 and miR-
146a in BMDMs prompted us to investigate the global
persistence of mature miRNAs, and to address whether
this persistence is the rule or an exception. To establish
a cell model where miRNA stability could be measured
following ablation of miRNA ﬁnal processing step, we
exploited Dicer1 genetic deletion. Accordingly, Dicer1
ﬂox/
ﬂoxxCre/Esr1 mice, in which the majority of the second
RNase III domain of Dicer1 can ubiquitously be deleted
following OHT treatment, thus resulting in ablation of
Dicer1 activity (21,22) were used. In a similar mouse
model to the one described here, Dicer1 ablation by
OHT treatment of mouse MEFs has previously been
shown to promote p53 induction and decrease cell prolif-
eration, thus compromising survival of these cells (29).
Since MEF immortalization through expression of the
simian virus 40 large T-antigen (SV40 TAg) results in
p53 inactivation (30) and yields rapidly dividing stable
cell lines, we posited that TAg immortalization of MEFs
from Dicer1
ﬂox/ﬂoxxCre/Esr1 mice would mostly rescue
cell survival on OHT treatment.
Following TAg immortalization of Dicer1
ﬂox/ﬂoxxCre/
Esr1 MEFs, the ability of OHT to induce Dicer1
genomic ablation was tested. Importantly, 500nM OHT
treatment of the cells resulted in the robust recombination
of the cells (at least >93% in all experiments) as measured
through the levels of remaining wild-type Dicer1 mRNA
(Figure 2A). In accord with TAg-inhibition of p53-induced
cell death following Dicer1 ablation, cell proliferation was
unaffected within 90–120h following OHT treatment (data
not shown). However, the MEFs stopped proliferating after
170–190h of culture in medium supplemented with 100nM
OHT (i.e. 6–8 cell divisions), conﬁrming previous observa-
tions (29). To conﬁrm loss of processing of pre-miRNAs,
the ability of a Dicer1-substrate small interfering RNA
(D-siEGFP) to promote RNA interference against EGFP
stably expressed by the cells was measured. Such a Dicer1-
substrate is based on a 25-nt sense strand complemen-
tary to a 27-nt targeting strand, generating an asymmetric
duplex with one overhang and one blunt end
(Supplementary Figure S1B). This design allows for
speciﬁc Dicer1 cleavage and enhanced selection of the
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Figure 4. Widespread variation of miRNA decay in slow dividing
primary macrophages. (A–C) BMDMs from Dicer1
ﬂox/ﬂoxxCre/Esr1
mice were treated (OHT +) or not (OHT  ) for 48h with 500nM
OHT as described in ‘Methods’ section. The cells were collected every
24h from Day 3 (T=72h) following initial OHT addition. (A)
GAPDH-normalized wild-type Dicer1 mRNA levels quantiﬁed by
RT-qPCR were reported to values obtained for NT cells on Day 3 in
biological triplicate. (B) OHT-treated (+) or not ( ) BMDMs were
stimulated with 10ng/ml LPS (+) or not (LPS  ) for 6h and collected
for RNA extraction. GAPDH-normalized pri-miR-155 and
snoRNA-202 normalized miR-155 levels are shown relative to the
values obtained in non-OHT and non-LPS stimulated cells from bio-
logical triplicate. (C) Seven miRNAs were measured from biological
triplicate of cells stimulated with OHT, normalized to snoRNA-202
and reported to the initial values at T=72h (i.e. Day 3 following
initial OHT treatment). Highlighted in grey is the variation of
miRNA decay observed between the seven miRNAs analysed, and
ﬁtted exponential regression with halving-time is shown for miR-125b
and miR-155. (A–C) SEM is shown.
5698 Nucleic Acids Research, 2011,Vol.39, No. 13targeting strand (31). Importantly, RNAi efﬁciency dir-
ectly relates to Dicer1 processing of these asymmetric
siRNAs (31). In our experiments, D-siEGFP lost its
ability to trigger EGFP down-regulation 3 days post-
OHT treatment, suggesting ablation of Dicer1 activity
and de novo miRNA synthesis was ineffective from then
on (Figure 2B).
To capture a global trend of the variations of miRNA
levels following ablation of Dicer1 processing, RNA was
collected from actively dividing cells at Days 3–5 post-
OHT treatment and the expression of 335 mouse
miRNAs was analysed with TaqMan RT-qPCR low
density arrays. In this preliminary screen, we identiﬁed
104 miRNAs expressed at signiﬁcant levels in the cells,
which were consistently decreased with time (‘Methods’
and Supplementary Table S1). The average decrease of
intracellular miRNA concentration for these 104
miRNAs was constant between Days 3 and 4, and 4 and
5, and followed an exponential decrease curve with a
halving-time of 21.6h (Figure 2C). The robustness of the
RT-qPCR arrays was validated by individually measuring
the levels of a panel of six miRNAs (with varying basal
abundance) (Figure 2D; Supplementary Figure S2A). A
good correlation (0.88) was seen between individual
PCRs and PCR-arrays and the average decrease halving-
time for these six miRNAs was also 21.6h, indicating that
this panel of miRNAs gave a good representation of the
global trend of miRNA decrease (Figure 2D and
Supplementary Figure S2B). Noteworthy, the exponential
trend of miRNA decrease was closely correlated with
miRNA intracellular concentration being related to
cellular division.
Modelling of miRNA decay
Having identiﬁed a panel of miRNAs representing the
global trend of miRNA decay, we set out to establish a
model of miRNA degradation compensating for the loss
of miRNA per cell due to cell division. In addition, the
impact of the residual cell population that evades OHT
treatment and produces normal levels of miRNAs was
also taken into account. Samples were collected from
MEFs treated with two different doses of OHT, and the
levels of the six miRNAs measured with time, and cell
proliferation assessed (Figure 3A–C and Supplementary
Figure S3). Using exponential ﬁtting to the averaged ex-
perimental data from the six miRNAs (Figure 3C), we ﬁrst
established a model of miRNA decrease in the samples
treated with 500nM OHT in which 99.5% of the cells
lost Dicer1 expression (Figure 3A and D, see FM-99.5%
curve and ‘Methods’ section). To conﬁrm the validity of
the mathematical prediction of miRNA decay function
of cell recombination, we modelled miRNA decrease in
a situation where 50% of the cells had recombined
(M-50%—Figure 3D). The resulting predicted miRNA
decrease closely matched the experimental data set where
48.7% of the cells had recombined, obtained with 10nM
OHT (Figure 3D—compare M-50% curve and the distri-
bution of 10nM experimental points). This suggested
faithful modelling of miRNA intracellular decrease
function of cell recombination, and allowed us to infer
miRNA decrease in a hypothetic pure cell population
(with 100%-Dicer1-deﬁcient cells—Figure 3D, see
M-100%).
The analysis of cell proliferation conﬁrmed that OHT
treatment did not signiﬁcantly impact on cell growth over
the course of the experiment (Figure 3B—compare
500nM OHT-treated and non-treated cells). Relying on
this experimental determination of cell proliferation, a
model of miRNA decrease as a function of cell div-
ision was established, assuming that each divided cell
received half the initial intracellular content of miRNAs
(Supplementary Figure S3B and ‘Methods’ section).
Subtraction of this function from the predicted miRNA
decrease in pure cell population (M-100%) resulted in the
model of miRNA decay, independent of cell proliferation,
as a function of time (Figure 3E, see ‘predicted av. decay’
curve). Based on the averaged experimental measurements
of the panel of six miRNAs, the theoretic average miRNA
half-life thus obtained was 119h ( 5 days). Importantly,
we noticed large differences in predicted half-lives, ranging
from  101h for miR-155 ( 4 days), up to 225h ( 9 days)
for miR-125b, suggesting that although generally ex-
tremely stable, some miRNA sequences were signiﬁcantly
more stable than others following Dicer1 processing
(Figure 3E—compare miR-125b and miR-155, and
Supplementary Figure S3C).
miRNA persistence varies between miRNAs
To investigate further the observations that some
miRNAs are more persistent than others in non-dividing
cells and to validate the relevance of the predicted miRNA
half-life, the decay rates of miRNA following Dicer1
ablation were measured in slow dividing primary
BMDMs. OHT treatment of BMDMs from Dicer1
ﬂox/
ﬂoxxCre/Esr1 mice promoted Dicer1 genomic ablation in
>98% of the cells as seen with the levels of wild-type
Dicer1 mRNA 3 days after OHT treatment (Figure 4A).
To determine the point in time at which Dicer1 enzymatic
processing of pre-miRNA was ablated following
OHT-induced Dicer1 genetic deletion, LPS treatment of
BMDMs was used to induce the miR-155 pri and mature
forms (Figure 4B). Processing of pri-miR-155 into mature
miR-155 was strongly impeded 3 days after OHT treat-
ment when compared to the non-OHT-treated cells,
although a small proportion of de novo miR-155 could
still be synthesized indicating that some cells still exerted
Dicer1 enzymatic activity at this point in time.
Quantiﬁcation of the average basal levels of seven
miRNAs with varying abundance from Day 3 following
OHT treatment conﬁrmed the great stability of miRNAs
following Dicer1 processing (Figure 4C). However, in
agreement with our predictions from the measurement
of miRNA levels in MEFs, we observed that miRNAs
decayed with varying kinetics (the fastest and slowest
being miR-155/miR-107 and miR-125b, respectively)
(Figure 4C). Collectively, these results support the notion
that although generally extremely stable, miRNAs are
turned over with varying rates following synthesis.
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The steady-state level of miRNA is inﬂuenced by three
main parameters: transcription, processing and decay.
The last decade has seen a remarkable effort to charac-
terize the parameters that affect the transcriptional
activity of select miRNAs, and more recently, their pro-
cessing, highlighting sophisticated mechanisms of control
(8). It is proposed that a minimum of 100 molecules
of miRNAs per cell are required for their translational
regulatory effects (10,32). Control of steady-state
miRNA concentration therefore directly relates to the
control of miRNA function. Interestingly, although
crucial for the regulation of steady-state miRNA levels,
little has been uncovered about the regulation of
miRNA half-life and stability in the cell, following pro-
cessing. In analogy to what is seen with mRNA (33), it can
be speculated that determining the half-life of a given
miRNA could directly inform on its biological function.
Stimulation of immune cells with pathogen-derived
products results in the nuclear factor k-B-dependent
rapid induction of mature miR-155, miR-146a and
miR-21 (26,34). The strict regulation of nuclear factor
k-B transcriptional activity results in the transient induc-
tion of most of its targets, and we show here that the
primary transcripts of these three miRNAs are consistent
with this (Figures 1A–C). However, the mature form
of these miRNAs accumulated in the cells and persisted
at high levels in the absence of induced precursors. It is
worth noting here that miR-155 appeared to be less stable
than miR-21 and miR-146a and was the only miRNA to
decrease over the 72h of observation (Figure 1A). This
stability was not exclusive of the induced forms of
these miRNAs, as transfection of synthetic miRNAs
conﬁrmed that the mature forms of miR-155 and
miR-21 were detectable >48h after transfection (Figure
1D). Similar observations were made in primary B cells,
indicating that the persistence of these miRNAs following
induction was not restricted to BMDMs (Supplementary
Figure S1).
To determine whether the persistence of these three
miRNAs was the rule or an exception, we investigated
the global decay of miRNAs following synthesis.
Although other studies have used traditional transcrip-
tional shutdown experiments to determine miRNA decay
rates in different cell lines (NIH3T3, RPE-1, ES cells and
HEK293 cells), these attempts failed to measure any sig-
niﬁcant decrease of miRNA concentrations over the
course of their experimental set-up (14,35). We reasoned
that the extent of miRNA half-life was such that transcrip-
tional shutdown-type experiments could not be prolonged
enough to allow for an accurate determination of miRNA
decay. An alternative approach to global transcriptional
shutdown is the selective blocking of miRNA maturation
by Dicer1, through ablation of Dicer1 enzymatic activity.
Our analysis of 104 miRNAs by TaqMan RT-qPCR, the
current gold standard for miRNA quantiﬁcation (36),
indicated that the global miRNA decrease followed an
exponential function with a half-life of 21.6h, following
loss of Dicer1 enzymatic activity. These ﬁndings strongly
supported the concept that intracellular miRNA levels
were mostly affected by dilution from cellular division.
Noteworthy, we found 27 miRNAs that were only detected
on Day 3, possibly reﬂecting their more rapid decay as
previously proposed for miR-382 (35) (Supplementary
Table S1, ‘Rapily degraded?’). Further analyses would
be required to draw speciﬁc conclusions on the behaviour
of individual miRNAs identiﬁed in this preliminary
screen.
In order to calculate miRNA half-life independent
of cellular division and any residual Dicer1 activity, the
decay rates of a representative panel of six miRNAs were
measured in two populations of cells with varying Dicer1
recombination efﬁciency (one population averaging 50%,
the other 99.5%) and a mathematical model established to
predict miRNA stability in a hypothetical non-dividing
cell population entirely devoid of Dicer1 function
(Figure 3). Correction of cell proliferation revealed an
extreme stability of miRNAs with a modelled half-life of
119h ( 5 days) for the averaged panel of miRNAs—
ranging with individual modelling from   99h and 101h
for let-7i and miR-155, up to 225h ( 9 days) for
miR-125b (see Supplementary Figure S3C for modelled
persistence of individual miRNAs studied). These predic-
tions of miRNA stability in non-dividing cells are in line
with other reports demonstrating that in vivo half-life of
mature miR-208 could extend up to 12 days (12), or that
the half-life of miRNA-loaded RISC complexes could
average  140h ( 6 days) following inducible shutdown
of an artiﬁcial miRNA expression (37). To conﬁrm further
the relevance of modelling of miRNA persistence, miRNA
decay was investigated in slow-dividing primary BMDMs
following Dicer1 ablation (Figure 4C). Due to the limited
division of these cells, we were able to establish a more
relevant picture of miRNA decay kinetics for speciﬁc
miRNAs without the need for mathematical correction.
Consistent with the studies performed in MEFs
(Figures 2D and 3E), miR-155 and miR-125b exerted
very different stabilities in BMDMs. While the half-life
of miR-125b was 211h, i.e.  9 days (which is concordant
with our modelled half-life for this miRNA), that of
miR-155 was only  28h, i.e. 3.5  less that predicted
from the MEFs model for this miRNA. This suggests
that miRNA stability might be differentially regulated in
different cell types—with BMDMs having a more rapid
turnover of a subset of select miRNAs. In agreement with
our initial observations of miRNA stability following in-
duction (Figure 1), basal levels of miR-21 and miR-146a
were signiﬁcantly more stable than that of miR-155 fol-
lowing Dicer1 ablation in BMDMs (Figure 4C). Although
all three miRNAs are rapidly induced to similar intracel-
lular levels following innate immune activation [(38) and
data not shown], these results indicate that miR-155 is
intrinsically less stable than miR-21 and miR-146a, and
consequently has less sustained regulatory effects.
Collectively, our data demonstrate that although >10 
more stable than mRNA (the median half-life of which is
 10h (33), some miRNAs such as miR-125b are more
persistent than others. Increased stability of select
miRNAs is unlikely to be related to a 30 modiﬁcation of
these miRNAs, as indicated by a recent genome-wide
study that failed to demonstrate an impact of 30
5700 Nucleic Acids Research, 2011,Vol.39, No. 13adenylation on miRNA stability (39). Preferential active
degradation of select miRNAs could be at play, however
the miRNA decay machinery characterized to date was
not found to be able to differentiate between miRNAs
(11,17). In their elegant work, Krol et al. (14) recently
demonstrated the rapid intracellular decrease of all
miRNAs measured following transcriptional shutdown,
in different types of neurons (e.g. from retina and
cortex). Intriguingly, the rapid decrease (within a couple
of hours) of intracellular miRNAs was only partial and
40–50% of initial levels remained untouched (8,14). Thus
a portion of miRNAs present in neurons could be subject
to rapid turnover while the rest would not, for instance
because of their subcellular localization (8). Accordingly,
we speculate that the decrease of the remaining 40–50%
of each miRNA (which are not affected by transcrip-
tional shutdown) in neurons would have much slower
kinetics, possibly similar to what we observe in our
model of non-dividing cells (i.e.  5–9 days). In fact, per-
sistence of select miRNAs for up to 2 months following
Dicer1 ablation has been reported in neurons in vivo (40).
Several reports have suggested the rapid intracellular
(within 4–8h) decrease of select miRNAs following stimu-
lation, such as innate immune recruitment (41–46). For
instance, levels of miR-125b were commonly found to
rapidly decrease (within 4–6h) in murine phagocytes
stimulated by LPS, by miRNA microarray and miRNA
RT-qPCR analyses (41,44). However, we failed to
measure such a rapid decrease in BMDMs stimulated
with LPS, although the differences could originate
from differences between the cells used and their in vitro
differentiation (data not shown). Assuming such a rapid
decay of miR-125b, our ﬁndings regarding the persist-
ence of miR-125b indicate the selective active decay of
this miRNA following stimulation. Whether or not ma-
chinery with preferential active degradation of select
miRNAs could carry out this task remains to be
determined, but this has been proposed to be the case
for miR-382 (35).
In summary, this work establishes the average miRNA
half-life independent of cell proliferation and provides
direct evidence that miRNA turnover can vary widely
among miRNAs. Recent insight into the regulation of
miRNA-mediated control of mRNA translation in mam-
malian cells has revealed that miRISC binding to target
mRNAs predominantly results in decreased mRNA levels
(47), and thereby mostly impacts on mRNA stability.
Whether or not the stability of a given miRNA correlates
with the overall half-life of its targets would be worthwhile
investigating, and might be informative on the biological
signiﬁcance of the variable persistence between miRNAs
reported here. For instance, the ﬁnding that miR-155 is
less stable than miR-146a and miR-21 highlights further
the different biological functions of these innate immune
miRNAs. Given that miRNA persistence is a function of
the miRNA and also the cell type considered, our work
stresses the need for the detailed characterization of a
target miRNA turnover, for translational approaches
aiming at blocking miRNA function through the use of
synthetic antagomirs. Our observations strongly suggest
that miRNA persistence relates to biological function,
and that better characterization of miRNA stability and
associated regulatory mechanisms should provide new
avenues for the characterization of their biological
functions.
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